...
首页> 外文期刊>Bioorganic and Medicinal Chemistry >Novel acetylcholinesterase inhibitor as increasing agent on rhythmic bladder contractions: SAR of 8-{3-(1-(3-fluorobenzyl)piperidin-4-yl)propanoyl}-1,2,5,6-tetrahydro-4H-py rrolo(3,2,1-ij)quinolin-4-one (TAK-802) and related compounds.
【24h】

Novel acetylcholinesterase inhibitor as increasing agent on rhythmic bladder contractions: SAR of 8-{3-(1-(3-fluorobenzyl)piperidin-4-yl)propanoyl}-1,2,5,6-tetrahydro-4H-py rrolo(3,2,1-ij)quinolin-4-one (TAK-802) and related compounds.

机译:新型乙酰胆碱酯酶抑制剂作为有节律性膀胱收缩的增强剂:SAR的8- {3-(1-(3-(氟代苄基)哌啶-4-基)丙酰基} -1,2,5,6-四氢-4H-py rrolo( 3,2,1-ij)喹啉-4-酮(TAK-802)和相关化合物。

获取原文
获取原文并翻译 | 示例

摘要

As part of an on-going investigation to develop an increasing agent on rhythmic bladder contractions, 1-aryl-3-(1-benzylpiperidin-4-yl)propanones were synthesized and examined as noncarbamate acetylcholinesterase (AChE) inhibitors. Among compounds with various aryl groups, 1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one derivative 9c was found to possess a potent AChE inhibition activity with an IC(50) value of 1.3nM. The compound 9c increased rhythmic bladder contractions in Guinea pigs and rats without affecting the basal intravesical pressure, which suggests that 9c may be useful for the treatment of voiding dysfunction caused by detrusor underactivity.
机译:作为开发有节奏的膀胱收缩增加剂的正在进行的研究的一部分,合成了1-芳基-3-(1-苄基哌啶-4-基)丙烷,并将其作为非氨基甲酸酯乙酰胆碱酯酶(AChE)抑制剂进行了研究。在具有各种芳基的化合物中,发现1,2,5,6-四氢-4H-吡咯并[3,2,1-ij]喹啉-4-酮衍生物9c具有有效的AChE抑制活性,且具有IC(50 )值1.3nM。化合物9c可增加豚鼠和大鼠的节律性膀胱收缩,而不会影响基础膀胱内压力,这表明9c可用于治疗逼尿肌功能不足引起的排尿功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号